NEW YORK (GenomeWeb News) – Four European research teams will use €38 million ($50.8 million) in funding from the European Union to harness genomic knowledge in developing new diagnostics and treatments for a range of rare diseases, Newcastle University said today.

Four new research programs were launched today by the International Rare Diseases Consortium (IRDiRC) that aim to use epigenetic, genetic, and whole-genome sequencing data to fuel development of these new applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.